NASDAQ:ATRS

Antares Pharma Earning Date

USA |NASDAQ |USD

ATRS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $0.03 $0.03 $0.03
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $49.22M $44.98M $40.00M

Antares Pharma's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

ATRS Earnings Date & History Chart

ATRS Earnings & Revenue Forecast

ATRS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $0.03 $0.02 $0.04
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $0.10 $0.09 $0.12
Dec 2022 6 $0.21 $0.13 $0.31

ATRS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.03 $0.03 $0.04
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $0.11 $0.11 $0.12
Dec 2022 0 / 0 $0.22 $0.22 $0.26

ATRS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 7 $51.35M $49.30M $53.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 7 $187.13M $184.65M $190.00M
Dec 2022 7 $232.32M $222.10M $240.94M

ATRS Earnings Date & Revenue History

ATRS Earnings History

|
Show More
Show More

ATRS Revenue History

|
Show More
Show More

Antares Pharma Next Earnings Date & Report

ATRS Next Earnings Date & Report Preview: Sep 2021 (FQ)

ATRS's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 7 analysts, the average EPS estimation for Antares Pharma's next quarterly earnings is $0.03, with a low EPS estimation of $0.02, and a high estimation of $0.03.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.03, the last 2 month trend is $0.03, and the 3 month trend is $0.03.

Based on 7 analysts, the average revenue estimation is $49.22M, with a low revenue estimation of $46.70M, and a high estimation of $51.60M.

Antares Pharma Previous Earnings Dates & Reports

ATRS Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Antares Pharma's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

ATRS's earnings per share (EPS) was $0.03, beating the consensus analysts forecast of $0.02 by 75.44%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by 50.00%, and higher than the same period a year before (Jun 2020) by 200.00%.

Revenues were $44.98M, better than the forecast of $43.32M by 3.83%, up by 6.88% from the previous quarter , and up by 38.89% from the same period last year.

The company reported a net income of $6.71M, 76.80% higher than the previous quarter, and higher by 208.32% than the same period a year before.

Free cash flow for the quarter was $5.16M , compared to $794.00K last quarter and $1.88M a year before.

ATRS ended the quarter with $31.74M in total debt, a decrease of -32.18% compared to the previous quarter, and a decrease of -32.27% compared to the same quarter a year before.

ATRS Previous Earnings Date & Report Recap: Dec 2020 (FY)

Antares Pharma's previous annual earnings date was Mar 2, 2021 for its fiscal year ended Dec 31, 2020.

ATRS's earnings per share (EPS) was $0.06, beating the consensus analysts forecast of $0.06 by 0.00%.

Revenues were $149.60M, better than the forecast of $146.94M by 1.81%, and up by 20.78% from previous year's revenue.

The company reported a net income of $56.20M.

Antares Pharma reported a free cash flow of $6.71M for its fiscal year, compared to $-12.96M a year ago.

The company ended the fiscal year with $42.10M in total debt, an increase of 1.10% compared to the previous year.